NVO · NYSE · Healthcare · Drug Manufacturers - General

Novo Nordisk

Past month
Price unavailable
  • 52W range35.12–64.16
  • P/E ratio11.28
  • Market cap201.31B

Latest news

Loading...

About

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovasc...

novonordisk.com